Processa Pharmaceuticals Bolsa (NASDAQ: PCSA)

Últimas noticias sobre Processa Pharmaceuticals (NASDAQ:PCSA) Bolsa

PROCESSA PHARMACEUTICALS INC

Processa Pharma

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals Inc

Macro Economic Events

WIIM

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods.

CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>), a leader in the field of masked, conditionally activated biologic therapeutics, today announced the pricing of an underwritten offering of 76,923,076 shares of its common stock at an offering price of $1.30 per share, before underwriting discounts and commissions. All of the shares are being offered by the Company. The gross proceeds from the offering are expected to be approximately $100 million before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on May 13, 2025, subject to customary closing conditions.
The Company intends to use the net proceeds from this offering for research and development, general corporate purposes and working capital needs.

News

Offerings

CTMX

CytomX to Raise $100M in Stock Offering, Pricing 76.9M Shares at $1.30 Each

Somnigroup International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGI#NYSE">SGI</a>, ", Company", or ", Somnigroup", ))) today announced the launch of a secondary offering (the "Offering") of 15,376,743 shares of its common stock, par value $0.01 per share, by the former majority shareholder of Mattress Firm Group Inc., which shareholder is a subsidiary of IBEX Topco B.V. (the "Selling Stockholder"). All of the shares of common stock are being sold by the Selling Stockholder, and Somnigroup will not receive any of the proceeds from the Offering.
Goldman Sachs &amp; Co. LLC is acting as the sole underwriter for the Offering.

Somnigroup International Announces Secondary Offering Of 15.4M Shares At $0.01 Par Value By IBEX Subsidiary

Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) sees Q3 sales of $918.782 million-$937.628 million vs $901.47 million analyst estimate.

Guidance

Sally Beauty Holdings Sees Q3 Sales $918.782M-$937.628M vs $901.47M Est

Benchmark analyst David Williams maintains D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and raises the price target from $8 to $14.

Price Target

Analyst Ratings

QBTS

Benchmark Maintains Buy on D-Wave Quantum, Raises Price Target to $14

On May 6, 2025, the Board of Directors approved an extension of the share repurchase program for an additional four-year period ending on September 30, 2029. Under this extension, the Company is authorized to repurchase its common stock up to the amount remaining under the initial 2017 authorization, which is currently $501.1 million.

Buybacks

Sally Beauty Holdings Board Approves 4-Year Extension to $501M Share Buyback Program, Now Running Through 2029

Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported today that its preliminary assets under management ("AUM") as of April 30, 2025 totaled approximately $231.4 billion. The month's AUM included FX appreciation of $5.1 billion, market depreciation of $0.9 billion, and net outflows of $0.2 billion.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="4" rowspan="1">
LAZARD, INC.
ASSETS UNDER MANAGEMENT ("AUM")
(unaudited)
($ in millions)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="2" rowspan="1">As of:</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">April 30,</td>
<td colspan="1" rowspan="1">March 31,</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">20251</td>
<td colspan="1" rowspan="1">2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Equity</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$176,313</td>
<td colspan="1" rowspan="1">$174,130</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fixed Income</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">46,341</td>
<td colspan="1" rowspan="1">44,024</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Other</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">8,754</td>
<td colspan="1" rowspan="1">9,273</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total AUM</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$231,408</td>
<td colspan="1" rowspan="1">$227,427</td>
</tr>
<tr>
<td colspan="4" rowspan="1">(1) Preliminary – subject to adjustment</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Lazard Reports $231.4 Billion in Assets Under Management, Driven by FX Gains and Strong Equity Growth

Telsey Advisory Group analyst Joseph Feldman maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Outperform and maintains $115 price target.

Telsey Advisory Group Maintains Outperform on Walmart, Maintains $115 Price Target

Benchmark analyst David Williams maintains Diodes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIOD#NASDAQ">DIOD</a>) with a Buy and lowers the price target from $65 to $55.

DIOD

Benchmark Maintains Buy on Diodes, Lowers Price Target to $55

Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.39 by 7.69 percent. This is a 20 percent increase over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $883.15 million which missed the analyst consensus estimate of $901.47 million by 2.03 percent. This is a 2.78 percent decrease over sales of $908.36 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Sally Beauty Holdings Q2 Adj. EPS $0.42 Beats $0.39 Estimate, Sales $883.15M Miss $901.47M Estimate

Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) affirms FY2025 sales outlook from $2.45 billion-$2.55 billion to $2.45 billion-$2.55 billion vs $2.48 billion estimate.

FTRE

Fortrea Holdings Affirms FY2025 Sales Guidance of $2.45B-$2.55B vs $2.48B Est

Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.07) by 128.57 percent. This is a 140 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $651.30 million which beat the analyst consensus estimate of $608.34 million by 7.06 percent. This is a 1.63 percent decrease over sales of $662.10 million the same period last year.

Fortrea Holdings Q1 Adj. EPS $0.02 Beats $(0.07) Estimate, Sales $651.30M Beat $608.34M Estimate

HC Wainwright &amp; Co. analyst Scott Buck maintains SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) with a Buy and lowers the price target from $26 to $18.

SOUN

HC Wainwright & Co. Maintains Buy on SoundHound AI, Lowers Price Target to $18

Babcock & Wilcox To Exchange $131.8M Of Senior Notes For $100.8M In New 8.75% Secured Notes Due 2030

On Friday, May 9th, U.S. markets closed mixed, as investors focused on Trump&#8217;s call to lower Chinese tariffs ahead of weekend trade talks. While earnings remained strong, concerns over trade tensions and economic risks kept markets subdued. Energy stocks gained, but healthcare lagged, and Fed officials warned of growing tariff-related risks.
According to economic data, U.S. jobless claims dropped by 13,000 to 228,000, beating the 230,000 estimate, while nonfarm labor productivity fell by 0.8%, slightly worse than the expected 0.7% decline.
Most S&amp;P 500 sectors ended higher Friday, led by real estate, consumer discretionary, and energy. Health care and communication services declined.
The Dow Jones Industrial Average was down 0.29% at 41,249.38, the S&amp;P 500 declined 0.07% to 5,659.91, and the Nasdaq was almost flat at 17,928.92.
Asia Markets Today
<ul class="wp-block-list">
<li>On Monday, Japan&#8217;s Nikkei 225 closed 0.42% higher at 37,660.00, led by gains in the Real Estate, Banking, and Textile sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 gained 0.03%, ending the session at 8,233.50, led by gains in the Energy, Resources, and Metals &amp; Mining sectors.</li>
<li>India&#8217;s Nifty 50 was up 3.81% at 24,924.05, and Nifty 500 rose 3.84% to 22,512.15.</li>
<li>China&#8217;s Shanghai Composite gained 0.82% to 3,369.24, and the Shanghai Shenzhen CSI 300 was up 1.16% to 3,890.61.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session 2.98% higher at 23,549.46.</li>
<li>The U.S. and China agreed to a 90-day pause and mutual tariff cuts, easing fears of further escalation. Stocks and currencies rallied, though some high levies remain and economic risks linger.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling" rel="noreferrer noopener">Apple, Amazon, Nvidia Rise In Monday Premarket As U.S., China Agree To 90-Day Tariff Truce: &#8216;Neither Side Wants A Decoupling&#8217;</a>
Eurozone at 05:45 AM ET
<ul class="wp-block-list">
<li>The European STOXX 50 index was up 1.85%.</li>
<li>Germany&#8217;s DAX index gained 1.12%.</li>
<li>France&#8217;s CAC 40 rose 1.51%.</li>
<li>The U.K.&#8217;s FTSE 100 index traded higher by 0.42%.</li>
<li>European stocks rose on hopes of a China-U.S. trade deal, oil prices climbed, and UniCredit posted record profits. Meanwhile, markets eyed a likely ECB rate cut in June.</li>
</ul>
Commodities at 05:45 AM ET
<ul class="wp-block-list">
<li>Crude Oil WTI was trading higher by 3.10% at $62.91/bbl, and Brent was up 2.88% at $65.69/bbl.</li>
<li>Natural Gas gained 0.55% to $3.816.</li>
<li>Gold was trading lower by 3.69% at $3,220.96, Silver was down 1.96% to $32.265, and Copper rose 0.11% to $4.6570.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were up 2.20%, S&amp;P 500 futures declined 2.82%, and Nasdaq 100 futures rose 3.80%.
Forex at 05:45 AM ET
<ul class="wp-block-list">
<li>The U.S. dollar index gained 1.31% to 101.66, the USD/JPY rose 1.89% to 148.11, and the USD/AUD rose 0.25% to 1.5635.</li>
<li>The dollar jumped to a one-month high after a U.S.-China tariff truce boosted investor confidence, lifting it sharply against the yen and Swiss franc. Easing geopolitical tensions and optimism over further trade talks also supported gains.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Advance On China-US Tariff Pause, Oil Gains 3% - Global Markets Today While US Slept

ImmunityBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 25 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $16.52 million which beat the analyst consensus estimate of $16.02 million by 3.13 percent. This is a 41.19K percent increase over sales of $40.00 thousand the same period last year.

IBRX

ImmunityBio Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $16.52M Beat $16.02M Estimate

The U.S. government is hemorrhaging hundreds of billions of dollars every year to fraud, a chunk of which is leeched by sophisticated overseas digital crime rings using stolen identities.
What Happened: The Government Accountability Office estimates up to $521 billion in fraud losses annually, but former GAO official Linda Miller, speaking <a href="https://www.youtube.com/watch?v=0WZjFRdHjkk">on</a> 60 Minutes, shares her belief that the real figure is closer to $750 billion. "We're coming up close to the $1 trillion amount," she said.
The problem intensified during COVID-19 when digital systems went online. "It was like they threw money in the air and just let people run around and grab it," Miller said. Federal Bureau of Investigation Cyber Division Chief Bryan Vorndran confirmed: "These are arguably digital gangs&#8230; their governments are not gonna interrupt their activity even if it's illegal."
A key 2024 FBI bust revealed $6 billion in fraudulent pandemic unemployment claims. In another case, the Chinese hacking group APT41 siphoned off $60 million by generating fake unemployment claims with stolen American identities.
Disaster aid, food stamps, tax refunds, and more federal programs are being targeted by these fraudsters. "It's whack-a-mole," Miller said. "They're seeing where better controls are being put in place and going where they haven't."
See Also: <a href="https://www.benzinga.com/25/05/45341262/trumps-millionaire-tax-more-of-a-symbolic-gesture-than-step-towards-reducing-inequality-warn-experts-its-going-to-give-a-lot-of-republicans-heartburn">Trump&#8217;s Millionaire Tax More Of A Symbolic Gesture Than Step Towards Reducing Inequality, Warn Experts: &#8216;It&#8217;s Going To Give A Lot Of Republicans Heartburn&#8217;</a>
Why It Matters: The U.S. government is a prime target due to its immense financial reach. "All of our <a href="https://www.benzinga.com/tech/25/05/45336132/major-data-breach-exposes-social-security-numbers-financial-records-and-much-more">personally identifiable information</a>&#8230; is available on the dark net," said Vorndran. "And it can likely be purchased." For as little as two dollars, criminals can buy the digital identities of Americans and make use of AI tools like deepfakes to <a href="https://www.benzinga.com/tech/25/02/43759346/massive-data-breach-exposes-americans-financial-details-names-card-numbers-pins-and-more-at-risk">sidestep security checks</a>.
Some perpetrators are reportedly on foreign payrolls. "They just wanna make money for themselves," Vorndran said of Chinese-linked APT41, which laundered stolen funds via shell companies. "Very little" of the $60 million they stole has been recovered.
DOGE, the Department of Government Efficiency under President Donald Trump&#8216;s administration, and led by Tesla Inc. CEO Elon Musk, <a href="https://www.benzinga.com/markets/25/04/45034082/elon-musks-doge-saves-160-billion-but-could-lead-to-billions-in-hidden-costs-for-taxpayers-warns-new-analysis-public-will-end-up-paying-for-this">claims to have saved taxpayers $160 billion</a>, but critics say it often confuses <a href="https://www.benzinga.com/25/05/45311187/the-picture-of-the-worlds-richest-man-killing-the-worlds-poorest-children-is-not-a-pretty-one-says-bill-gates-slamming-elon-musk-over-abrupt-usaid-cuts">spending on certain programs</a> with actual fraud. "You may not like spending on foreign fertilizer, but that's not fraud," Miller noted.
Despite <a href="https://www.benzinga.com/news/25/04/44707473/aprils-social-security-changes-how-new-rules-could-affect-your-check">efforts</a> to tackle this pressing issue, experts say fraud continues mostly unchecked. Vorndran admitted: "In the U.S. government, we're all outnumbered."
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45340947/mastercard-cfo-sees-paradigm-shift-away-from-web-browsers-for-shopping-says-ai-will-soon-let-people-shop-and-pay-through-chat">Mastercard CFO Says Shoppers Ready To Abandon The Web Browser In Favor Of AI Agents: &#8216;Paradigm Shift&#8217; Unfolding</a></li>
</ul>
Image Via Shutterstock

Government

General

US Fraud Losses May Hit $1 Trillion As Digital Gangs Exploit Stolen American Identities, Ex-GAO Official Says, With FBI Cyber Division Chief Admitting: 'All Of Our Personally Identifiable Information… Is Available On The Dark Net' For Just $2

American Bitcoin Corp. ("American Bitcoin" or the "Company"), a Bitcoin accumulation platform focused on building America's Bitcoin infrastructure backbone, today announced that it has entered into a definitive merger agreement with Gryphon Digital Mining, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) ("Gryphon") pursuant to which Gryphon will acquire American Bitcoin in a stock-for-stock merger transaction. Upon closing, the combined company will operate under the American Bitcoin brand, led by the management and board of directors of American Bitcoin. The combined company is expected to trade on Nasdaq under the ticker symbol "ABTC."
 &nbsp;

GRYP

Gryphon Digital to Merge With Hut 8 Corp Subsidiary American Bitcoin, Forming New Nasdaq-Listed Crypto Powerhouse 'ABTC'

Health Care

Management

Fortrea Announced That Thomas Pike Is Stepping Down From His Role As Fortrea's CEO And Chairman Of Its Board. Fortrea's Lead Independent Director, Peter Neupert, Will Serve As Interim CEO And Board Chair, Beginning May 13

United Parks &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.21) by 38.1 percent. This is a 70.59 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $286.90 million which missed the analyst consensus estimate of $294.02 million by 2.42 percent. This is a 3.53 percent decrease over sales of $297.40 million the same period last year.

Comments

Processa Pharmaceuticals

Noticias

Últimas noticias sobre Processa Pharmaceuticals (NASDAQ:PCSA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL